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Abstract We have identified and analyzed a 27-nucleotide sequence (U5 repressive lement, designated as USRE) at the U5 region of the human 
T-cell leukemia virus type I (HTLV-I) long terminal repeat (LTR) which is required for HTLV-I basal transcriptional repression. The basal 
promoter strength of constructs that contained eletions in the U5 region of the LTR was analyzed by chloramphenicol acetyltransferase (CAT) assays 
following transfection of HeLa cells or Jurkat T-cells in the presence or absence of viral transactivator tax protein. We consistently observed a 2- 
to 5-fold increase in basal promoter activity when sequences between +277 to +306 were deleted. In vivo competition experiments uggested that 
the U5 DNA fragment from +269 to +295 contains a functional repressive lement (USRE). Using gel mobility shift assays, we have purifled a highly 
enriched fraction that could specifically bind USRE. This DNA afbnity column fraction contained three major detectable proteins on sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis with silver staining: llO-, 80- and ‘IO-kDa proteins. The llO-kDa protein appeared to be a novel 
DNA-binding protein whose characteristics are still obscure, while the 70- and IO-kDa proteins were shown to be related to the human autoantigen 
Ku, the Ku (p701p80) complex, as demonstrated by amino acid sequencing and immunological analyses. As Ku is known to be involved in 
transcriptional regulation, the specific interaction of Ku with USRE raises intriguing possibilities for its function in Hl?_V-I basal transcriptional 
repression. 
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1. Iutroduction 
Human T cell leukemia virus type I (HTLV-I) is an ex- 
ogenous human retrovirus that has been shown to be the etio- 
logic agent of a type of acute T-cell leukemia, known as adult 
T-cell leukemia (ATL), as well as a neurological disorder, 
known as HTLV-I-associated myelopathy or tropical spastic 
paraparesis (HAMfTSP) [l-6], and an eye disease, HTLV-I 
uveitis [7]. The latter two diseases are considered to be out- 
comes of immune disorders caused by HTLV-I infection. After 
infection into humans, the virus requires a long latent period 
until the onset of such diseases [8]. The full mechanism of the 
viral latency has not been uncovered yet. Analysis of HTLV-I 
gene expression in vitro, however, provides some important 
information on the mechanisms of the viral latent infection and 
activation from the latent state. 
After integrating into host chromosomal DNA, the expres- 
sion of the viral genes is known to be regulated by various viral 
and host nuclear factors through the viral 5’ long terminal 
repeat (LTR). The 21-bp repeat elements, TRE-1 (HTLV-I-tax 
protein responsive element l), are required for the transactiva- 
tion of the HTLV-I tax protein that is reported to bind indi- 
rectly to the enhancer elements through host cell nuclear factors 
[9-l 11. The cellular nuclear factors such as SPl, TIF-1, Ets 
and Myb interact with the LTR at the region located between 
two proximal 21-bp repeats, TRE-2 (Tax responsive lement 2) 
[12-151. 
Moreover, sequences downstream of the RNA initiation site, 
including the R and the U5 regions, have been shown to be 
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important for HTLV-I expression. A 137-bp fragment (+I04 to 
+ 240) [ 161 or a 235-bp fragment (+ 32 to + 266 [17] was reported 
to increase the level of HTLV-I gene expression. An 82-bp 
fragment (+ 266 to + 347) was shown to function as an RNA 
element for post-transcriptional repression [ 171. A 45-bp frag- 
ment at the boundary of the R/U5 region functions for HTLV-I 
basal transcriptional activation [18]. The R region of the LTR 
also contains the enhancer activity, and cellular binding factors 
(YB-1) to this enhancer region were characterized [19,20]. 
HTLV-I LTR suppression was recently reported to be associ- 
ated with a cyclic-AMP responsive element binding protein 
(CREB) binding in the R region (+205 to +227) [21]. 
The HTLV-I rex protein is known to be the viral post-tran- 
scriptional regulator that recognizes the rex-responsive lement 
(RXE) of the viral transcripts and enhances unspliced and 
singly spliced forms of viral transcripts resulting in the increase 
of the production of gaglpol and env proteins, respectively [22]. 
Since tax and rex proteins are produced from a doubly spliced 
viral transcript (designated as taxlrex mRNA), the accumula- 
tion of rex proteins induces a decrease in the level of taxlrex 
mRNA, resulting in the down-regulation of viral gene expres- 
sion. Thus, in the viral latency, some contribution that gene 
expression is regulated at the post-transcriptional levels by rex- 
proteins has been suggested [23]. 
As mentioned above, the sequences within the U5 region 
have been identified as a c&acting repressive element of the 
LTR-directed gene expression at post-transcriptional level [17]. 
In this report, we show that a U5 sequence in the LTR has an 
ability to repress the HTLV-I basal transcription in the absence 
of tax-protein as well as in the presence of tax-protein. Several 
nuclear proteins from Jurkat T cells interacted with this U5 
region, which contains a functional repressive lement (USRE), 
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were determined. Moreover, we report that the autoantigen Ku 
protein is involved in the USRE-binding proteins. Ku is a heter- 
odimer of about 70- and 80-kDa proteins that characteristically 
binds the ends of DNA fragments in vitro and translocates to 
form multimeric complexes [24,25], and is suggested to play a 
role in transcription [26,27]. Possibilities for involvement of Ku 
in the US-mediated repression are discussed. 
2. Materials and methods 
2.1. Cell lines 
The following human cell lines were cultured in RPMI-1640 medium 
supplemented with 10% heat-inactivated fetal bovine serum (FBS) 
(RlOF medium): T-cell lines; Jurkat, Molt-4, CEM, MT-2, MT-4, TL- 
Gml , TL-Su, and H582, and non T-cell lines; Daudi, K562, U937 and 
NB9. A human T-cell line, TOM-l, was cultured in RlOF medium 
containing 100 units/ml of human recombinant interleukin-2 (Shionogi 
& Co., Ltd., Osaka, Japan). Other human non-T-cell lines, HeLa and 
LJ251, were cultured in Dulbecco’s modified Eagle’s medium supple- 
mented with 10% FBS. MT-2, MT-4, TL-Gml, TL-Su, H582, and 
TOM-l cells are HTLV-I infected T-cell lines. NB9, U251, CEM, K562, 
U937, and Daudi cells were kindly provided by the Japanese Cancer 
Research Resources Bank. The other cell lines were described previ- 
ously [28}. 
2.2. Oligonucleotides for probes and competitors 
The following oligonucleotides were synthesized using a DNA syn- 
thesizer (Cyclone Plus DNA Synthesizer, Model 391 PCR-MATE 
DNA Synthesizer, Applied Biosystems Inc., CA, USA): for USRE 
DNA (nucleotide numbers from + 269 to +295), a sense strand; S- 
AGCTTAAG’ITCCACCCCTfTCCCTlTCATTCA-3’ and an anti- 
sense strand; 5’-AGCTTGAATGAAAGGGAAAGGGGTGGAA- 
CTTA3’, for non-specific control DNA, a sense strand; S- 
AGCITCAGGTAGACTGGATCACTAGAGA-3’ and an anti- 
sense strand; S-AGC’ITCTCTAGTGATCGAAGCAGTCTACC- 
TGA-3’ (an additionallinker sequence corresponding to a restriction 
endonuclease Hind111 site is indicated by underlining), and for 
U5(+ 255 to +294) DNA, a sense strand S-GCCGTTACA- 
GATCGAAAGTTCCACCCCTTTCCCTTTCATT-3’ and an anti- 
sense strand; S-AATGAAAGGGAAAGGGGTGGAACMTC- 
GATCTGTAACGGC-3’. DNA sequence information from Seiki et al. 
[4] was used and nucleotide numbers referred to nucleotide positions 
relative to the cap site (+ 1). The synthesized DNAs were purified by 
electrophoresis in a 20% polyacrylamide/7 M urea gel and DE52 ion- 
exchange columns, precipitated in cold ethanol, and suspended in TE 
solution (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). 
The recessed 3’ end of double-stranded DNA was labeled by 
[a-‘*P]dCTP (Amersham, Buckingshamshire, UK) with the Klenow 
fragment of E. coli DNA polymerase (Takara Shuzoh, Kyoto, Japan). 
The 5’ end of synthetic oligonucleotides was labeled by T4 polynucleo- 
tide kinase (Takara Shuzoh) end labeling with [r-?]ATP (Amersham). 
2.3. CAT assay and in vivo competition assay 
Three chloramphenicol acetyltransferase (CAT) expression plasmids 
derived from the HTLV-I LTR promoter with the deletion mutants 
within the US region were constructed as follows (Fig. 1A); pBLTR-1, 
-2 and -9, in which the CAT gene was under the control of the U3-R-US 
(- 325 to + 316), (- 325 to + 276) and (- 325 to + 246) region of the 
LTR, respectively. pCHL.4 and pRSV-CAT plasmids, in which the 
CAT gene is under the control of the U3-R-U5 (- 325 to + 306) region 
of HTLV-I LTR [la] and under the control of the Rous sarcoma virus 
LTR, respectively, were also used. 
HeLa or Jurkat cells were transfected with the LTR-CAT expression 
plasmids with or without the tax protein expression plasmid pMAXneo 
[9] by using a Lipofectin reagent (GIBCO BRL; Gaithersburg, USA) 
in serum-free culture medium for 16 h, and further cultured for 48 h 
in medium containing 10% FBS. In in vivo competition experiments, 
DNA competitors were cotransfected into cells with the CAT expres- 
sion plasmids. Thereafter cells were recovered, and whole cell lysates 
in 0.25 M Tris-HCl (PH 7.8) were prepared by five cycles of freezing 
and thawing. The lysates were cleared by centrifugation at 15,000 x g 
for 10 min. The supematants were recovered, and assayed for CAT 
activities as previously described [29] using r,-threo-[dichloracetyl-l- 
“C]chloramphenicol (Amersham). The degree of acetylation of “‘C- 
chloramphenicol was quantified by autoradiography of by using a 
Bio-Image analyzer (Model BAloO; Fuji Film, Tokyo, Japan). 
2.4. Cell nuclear extracts 
Nuclear extracts were prepared from Jurkat cells according to the 
method of Dignam et al. PO]. Briefly, cells were washed with PBS, 
suspended in 5 packed volumes of ice-cold lysis buffer 1 (10 mM 
HEPES, pH 8.0, 10 mM KCl, 1.5 mM MgCl,, 0.5 mM dithiotbreitol 
(DTI’), 0.5 mM phenylmethylsulfonyl fluoride (PMSF), kept on ice for 
10 min, and centrifuged at 1,000 x g for 10 min. The cell pellet was 
resuspended in 2 volumes of ice-cold lysis buffer 1, homogenized by 
10-20 strokes with a Dounce homogenizer, and centrifuged at 1,000 x g 
for 10 min at 4OC. After discarding the supematant, he precipitate was 
recentrifuged at 25,000 x g for 20 min at 4°C. The nuclear pellet was 
resuspended in ice-cold extraction buffer 1 (20 mM HEPES, pH 8.0, 
0.5 M NaCl, 20% glycerol, 1.5 mM MgQ, ‘0.2 mM EDTA; 0.5 mM 
DTT. 0.5 mM PMSF) at a ratio of 2.5 ml/l@ cells. homoeenized bv 
10-26 strokes with a Dounce homogenizer, and kepton ice Lr 30 mid. 
After centrifugation at 25,000 x g for 30 min at 4”C, the supematant 
was dialyzed against dialysis buffer 2 (20 mM Tris-HCl, pH 8.0, 20% 
glycerol, 0.1 M KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF) 
for more than 8 h at 4°C. The dialyzed extract was cleared by centrif- 
ugation at 8,000 x g for 15 min, and the supematant was kept in ali- 
quots at - 80°C until use. 
A rapid preparation of nuclear extracts from various cell lines was 
performed according to Schreiber et al [31]. In brief, lo6 cells were 
washed with PBS, pelleted, and suspended in 0.4 ml of ice-cold lysis 
buffer 2 (10 mM HEPES, pH 7.9,lO mM KCl, 0.1 mM EDTA, 0.1 mM 
ethylene glycol-bis(beta-aminoethyl ether)-N,N,jV’,l\r-tetraacetic a id 
(EGTA), 1 ~mM DTT, 0.5 mM P&F). After 15 min, 25 ~1 of a 10% 
solution of Nonidet P-40 MP-40) was added. and the solution was . , 
vortexed vigorously for 10 s and centrifuged for 30 s in a microcentri- 
fuge. The nuclear pellet was resuspended in 50 ~1 of ice-cold extraction 
b&er 2 (20 mM HEPES, pH 7.9,0.4 M NaCl, 1 mM EDTA, 1 mM 
EGTA, 1 tiM D’IT, 1 mM PMSF), rocked vigorously for 15 min at 
4°C on a shaking platform (model MT-360, Tomy, Tokyo, Japan), and 
centrifuged for 5 min in a microcentrifuge. The supematant was col- 
lected, and kept at -80°C until use. 
2.5. Gel mobility shift assay 
The crude nuclear extracts or partially purified fractions were incu- 
bated with 3ZP-end-labeled double strand DNA probes in binding buffer 
1 (20 mM Tris-HCl, pH 7.4,50 mM NaCl, 1 mM DTT, 1 mM EDTA, 
5% glycerol) in the presence of poly(dI-dC)/poly(dIdC) (Pharmacia 
P-L Biochemicals Inc.. Wisconsin. USA) for 30 min at RT. In most 
cases, U5 fractions were incubated with the DNA probes without 
poly(dIdC)/poly(CdIdC). Aliquots of the reaction mixtures were 
loaded onto a 5% polyacrylamide gel, and the samples were electro- 
phoresed for 90 min at 150 V in the electrophoresis buffer (TAE; 40 mM 
Tris acetate buffer, 1 mM EDTA). The mobility retarded DNA bands 
were visualized either by autoradiography or by using a BAlOO Bio- 
Image Analyzer. 
For supershift assays, 1 ,ul of the appropriate antiserum was added 
to the binding reaction 15 min prior to the loading of the gel. 
2.6. USRE DNA-coupled Sepharose beads 
One gram of activated CNBr-Sepharose 4B (Pharmacia, Uppsala, 
Sweden) was treated with 15 ml of 1 mM HCl for 15 min, washed with 
150 ml of 1 mM HCl and then with 10 mM phosphate buffer (PB, pH 
8.0), and suspended in 3.5 ml of PB. Immediately, 200 pg of the USRE 
double strand DNA fragment were added to the Sepharose solution. 
After incubation for 2 h at 25°C 0.8 ml of 1 M Tris @H 8.0) was added 
to the solution and further incubated for 4 h at 25‘C. After washing 
extensively with Tris buffer (10 mM Tris, 0.1 M NaCl, 1 mM EDTA, 
pH 8.0), the USRE DNA-coupled Sepharose beads were suspended in 
Tris buffer containing 0.02% sodium azide, and kept at 4’C until use. 
2.7. Purification of VSRE DNA binding proteins 
Frozen stocks of the Jurkat crude nuclear extracts were thawed on 
ice and applied to the heparin-agarose (GIBCO BRL; Gaithersburg, 
USA) column (2 ml extract/l ml heparin-agarose) which was prewashed 
with TM buffer (50 mM Tris-HCl, pH 8.0; 12.5 mM MgCl,, 1 mM 
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A u3 R ; u5 
1 2 3 4 1234 
-321 -200 -100 +316 
-_ pBLTR-1 
+116 
--1 CAT pBLTR-2 
Fold induction 0 1 5.0 5.0 0 1 2.1 2.3 
C Hela cells Jurkat cells D 
1234 123 4 
pBLTR-2/pBLTR-1 4.2 f 0.7 2.3 f 0.4 
pBLTR-9/pBLTR-1 4.3 f 0.5 2.4 f 0.7 
Fold induction 1 7.8 2.7 15.8 1 18.7 1.4 40.0 
Fig. 1. (A.) Schematic diagram of three CAT expression plasmids driven by the downstream deletion mutants of the HTLV-I LTR promoter, 
pBLTR-1, -2, and -9. All constructs contained intact U3 and R sequences and various sequences of the U5 region are as described in the text. Numbers 
refer to nucleotide positions relative to the cap site (+l). The TATA box and three 21-bp repeat elements, TRE-1, in the U3 region are indicated 
by a stippled box and open boxes, respectively. Another small stippled box in the U5 region of pBLTR-I indicates the USRE region. CAT, the open 
reading frame of the chloramphenicol acetyltransferase g ne. (B) Results of a representative experiment in the absence of tax protein are shown. HeLa 
or Jurkat cells were transfected with 2 ,ug of control pUC13 (lane 1), pBLTR-1 (lane 2), -2 (lane 3), and -9 (lane 4), and 48 h later CAT activity in 
the cell lysates (500 pg protein per assay) was determined. For each sample, the percent conversion of chloramphenicol to its acetylated forms is 
measured. For pBLTR-2 and -9, the percentage of chloramphenicol acetylation compared with that of pBLTR-1 was determined and the fold 
induction was calculated. (C) Significant differences in the promoter activity of pBLTR-1 compared with those of pBLTR-2 and -9. HeLa or Jurkat 
cells were transfected with the plasmids, pBLTR-1, -2, and -9. Promoter activity was determined by CAT analysis. The CAT activity of each deletion 
mutant construct was compared with the activity of the pBLTR-1 construct in each cell line. Results are the means ?r SE. of the mean for at least 
three independent experiments. (D) Results of a representative experiment in the presence of tax protein are shown. pBLTR-1 (lanes 1 and 2) or 
pBLTR-2 (lanes 3 and 4) were co-transfected into cells with (lanes 2 and 4) or without the tax protein expression plasmid pMAXneo (lanes 1 and 
3). 48 h later, 50 pg protein of the cell lysates were assayed. For pBLTR-1 in the presence of tax protein and pBLTR-2 in the presence or absence 
of tax protein, the percentage of chloramphenicol acetylation compared with that of pBLTR-1 in the absence of tax protein was determined and 
the fold induction was calculated. 
EDTA, 20% glycerol, 1 mM DTT) containing 1.0 M KC1 and equili- 
brated with ice-cold 0.1 M KCI-TM buffer. The column was washed 
with 2 bed volumes of 0.1 M KCl-TM buffer, and stepwise luted with 
0.2 M KCl-TM, 0.4 M KCI-TM and 0.6 M KCl-TM buffer. The eluted 
fractions were assayed for their binding activities to the USRE DNA 
probe in the gel mobility shift assay. The DNA-binding activity was 
enriched in fractions eluted with 0.4 M KCI-TM buffer, named Hep 
(0.4 M). This fraction was either dialyzed against 0.1 M KCl-TM buffer 
or diluted to about 0.1 M KC1 by adding TM buffer, and applied to 
the USRE DNA-Sepharose column equilibrated with ice-cold 0.1 M 
KCl-TM buffer. After incubation for 1 h at 4°C the column was 
washed with 4 bed volumes of 0.1 M KCl-TM buffer, and stepwise 
eluted with 0.2 M KCl-TM, 0.4 M KCl-TM and 0.6 M KC1 TM buffer. 
The DNA-binding activity was enriched in 0.4 M KCI-TM buffer, 
named U5(0.4M), and kept in aliquots at - 80°C. 
2.8. Amino acid sequencing 
The amino-terminal amino acid sequence of the 1 lo-, 80-, and 70- 
kDa proteins was determined by the method of Matsudaira [32] with 
minor modifications. A large-scale U5(0.4M) fraction of Jurkat nuclear 
proteins was electrophoresed and then electrotransferred to a PVDF 
membrane (Trans.-Blot Transfer Medium; BIO-RAD Lab., CA, USA). 
After being stained with 0.1% Amid0 black lOB, the membrane pieces 
with 1 lo-, 80-, and 70-kDa proteins were excised and analyzed with an 
amino acid sequencer (model PSQ-1; Shimadz Corporation, Kyoto, 
Japan). 
3. Results 
3.1. Characterization of the U5 region of HTLV-I LTR 
The U5 sequence in the HTLV-I LTR was previously sug- 
gested to contain a repressive lement for viral gene expression 
when transactivatecl with tax protein at a post-transcriptional 
level [17].To further examine this repression mechanism, we 
prepared three CAT expression plasmids derived from the LTR 
promoter with the deletion mutants within the U5 region as 
shown in Fig. 1A: pBLTR-1, -2 and -9, in which the CAT gene 
was under the control of the U3-R-U5 (-325/+316), (-325/ 
+276), and (-325/+246), region of the LTR, respectively. 
We observed that pBLTR-1 expressed a week CAT activity 
when transfected into HeLa or Jurkat cells in the absence of 
viral transactivator tax protein (Fig. 1B). The same level of the 
CAT activity was observed in transfectants with the pCHL4 
plasmid (data not shown), in which the CAT gene is under the 
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Fig. 2. Gel mobility shift assays of the Jurkat nuclear factors. Gel mobility shift assays were performed with 10 ng of a “P-labeled R-U5 DNA 
(A and B) or USRE DNA probe (C) and approximately 2pg of Jurkat crude nuclear extracts as described in section 2. (A) Reactions were performed 
in the absence (lane 3) or in the presence of a lOO-fold molar excess of competitors the R-US DNA (179-bp, +128 to + 306) (lane l), and the pX 
region DNA (159-bp, +7,358 to +7,516) (lane 2). (B) Reactions were performed in the absence (lane 2) or in the presence of a lOO- or 500-fold (lane 
3 or 4, respectively) molar excess of the USRE DNA as a competitor. Lane 1 shows a reaction without Jurkat nuclear extracts. An arrowhead indicates 
a specific competition band with the USRE DNA. (C) Reactions were performed in the absence (lane 1) or in the presence of a lOO- or 500-fold (lanes 
2 and 3, respectively) molar excess of a specific competitor USRE DNA. An arrowhead indicates a specitic band binding to the USRE DNA. 
control of the U3-R-U5 (-325/+306), region of LTR [16]. In 
contrast, pBLTR-2 showed about 5- or 2-fold increases of CAT 
activities in HeLa or Jurkat cells, respectively. The similar aug- 
mentation of CAT activities was observed in transfectants with 
pBLTR-9 (Fig. 1B). Moreover, as shown in Fig. lC, sign&ant 
differences in the promoter activity of pBLTR-1 compared with 
those of pBLTR-2 and -9 were confirmed by at least three 
independent experiments, indicating that the U5 region con- 
taining the sequence from +277 to + 306 exerts a repressive 
Table 1 
In vivo competition experiments” 
Reporter Competitor Relative 
CAT 
activity 
Experiment 1 
pc1-11-4 (4.2 pg) poly(dIdC)/poly(dI-dC) (3 pg) 1.0 
USRE DNA (3 pg) 2.7 
Experiment 2 
PBITR-l (2 pg) Non-spe DNA 
USRE DNA :z l.O 2.9 
Experiment 3 
PBUI-R-l (2 pg) Non-spe DNA 
USRE DNA ii % l.O 4.3 
pRSV-CAT (2 pg) Non-spe DNA 
USRE DNA I: ;:; ::; 
“Cotransfection of each of the reporter plasmids with a specific or a 
non-spe&ic competitor into Jurkat cells was performed, and the per- 
cent CAT conversion determined as described in the text. The results 
were normalized to the percent CAT conversion of the reporter with 
a non-specific competitor. A specific competitor, USRE DNA. Non- 
specific competitors, poly(dIdC)/poly(dI-dC) and Non-specific DNA 
were as described in sector 2. 
effect on the LTR-directed expression in the absence of tax 
protein. Thus, these results suggest another possibility that the 
U5 region (+ 277 to + 306) is responsible for repressing the basal 
HTLV-I gene expression. 
As the U5 segment (+ 266 to + 4 15) that contains our + 277/ 
+306 sequence was shown to exert its repressive effect when 
transactivated with tax protein [ 171, we then examined whether 
tax protein affects this US-mediated repression. When cotrans- 
fected with the tax protein expression plasmid pMAXneo [9], 
pBLTR-2 showed about 2-fold augmentation of CAT activities 
in HeLa or Jurkat cells compared with pBLTR-1, although the 
two constructs, pBLTR-1 and -2, showed strong promoter ac- 
tivities (Fig. 1D). The result might suggest hat this US-medi- 
ated repression is independent of tax protein. 
3.2. Detection of USFUGbinding proteins in Jurkut nuclear 
extracts 
Ceilular proteins interacting with the U5 segment might be 
possible to fulfil the repression of gene expression from the 
LTR. We then prepared crude nuclear extracts from Jurkat 
cells and looked at nuclear proteins binding to the U5 segment 
by using a gel mobility shift assay. First, six major shift bands 
were detectable with the 32P-labeled R-U5 DNA probe (SucI- 
BglI fragment: 179-bp, from + 128 to + 306), which contains the 
+ 247/+ 306 sequence in the LTR U5 region. Of these bands, all 
disappeared in the presence of a cold R-U5 DNA competitor 
but not in the presence of a cold pX DNA competitor (Fig. 2A), 
while only one was significantly reduced in the presence of a 
cold USRE DNA probe (+270/+ 296) as a competitor (Fig. 2B), 
suggesting that the Jurkat nuclear extracts contain proteins 
binding to the USRE DNA. Then, in gel mobility shift assays 
with the 32P-1abeled USRE DNA probe (Fig. 2C), one major 
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shift band was detectable. The cold USRE DNA competitor 
inhibited this shift band formation, whereas a non-specific cold 
DNA fragment had no effect at all. These results indicate that 
Jurkat nuclear extracts contain proteins that specifically inter- 
act with USRE within HTLV-I LTR. 
To examine whether the USRE-binding proteins are respon- 
sible for the US-mediated repression, we next carried out in 
vivo competition experiments. As shown in Table 1, only when 
the USRE DNA was used as a competitor, the repression effect 
of pBLTR-1 disappeared, whereas the CAT activities of the 
control pRSV-CAT were not affected, indicating that USRE 
contains a functional repressive lement. In addition, the results 
suggest he possibility for involvement of the USRE-binding 
proteins in the US-mediated repression. 
3.3. Purification of U5RE-binding proteins 
USRE-binding proteins were purified by several chromatog- 
raphy purification steps including passage through heparin- 
agarose and the USRE DNA-Sepharose columns as described 
in section 2. Jurkat crude nuclear extracts were applied to the 
heparin-agarose column in 0.1 M KCl-TM buffer, and eluted 
stepwise by increasing the concentration of KCl. The USRE 
DNA-binding activity was monitored by the gel mobility shift 
assay, and was found to be enriched in fractions eluted with 
0.4 M KCl-TM buffer (Fig. 3A). These fractions, named 
Hep(OdM), were applied to the USRE DNA-Sepharose col- 
umn. The binding activity was again retained in 0.2 M KCl-TM 
buffer and eluted with 0.4 M KCl-TM buffer, designated 
U5(0.4M) (Fig. 3B). The profiles of the shift bands in these 
purified fractions are shown to be exactly the same as in the 
(A) (u) 
1 2 3 4 1 2 3 4 
Fig. 3. Gel mobility shift patterns of purified nuclear proteins with a 
32P-labeled USRE DNA as a nrobe. The fractions of the Jurkat nuclear 
proteins purified as descriheh in section 2 were used. (A) Using the 
0.4 M KC1 fractions (I-Iep(0.4M)) of the heparin column (lanes l-3), 
the specificity of the major gel shift complexes i demonstrated by
competition with specific USRE (lane 3) and non-specific DNA compe- 
titors (lane 2) at a lOO-fold molar excess. Lane 4, no nuclear protein 
control. (B) Hep(0.4M) (lane 1) and the 0.2 KC1 fractions (U5(0.2M)) 
(lane 2) and the first and second tubes of the 0.4 M KC1 fractions 
(U5(0.4M)-1 and -2 respectively) (lanes 3 and 4, respectively) of the 
DNA affinity column were used for the assay. An arrowhead indicates 
a specific band binding to the USRE DNA. 
91 
66 
45 
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Fig. 4. SDS-gel electrophoresis of the purified USRE DNA binding 
proteins. The Jurkat crude nuclear extracts were applied to the heparin 
&mn and subsequently to the DNA-affinity column as described in 
section 2. Proteins of the henarin column ~urifkd fraction, HeD(0.4M) 
(lane 1) and the DNA-afli&ty purified fmctions, U5(0.4M)-1 and -2 
fractions (the first and second tubes were applied on lanes 2 and 3, 
respectively) were separated on a SDS-polyacrylamide gel and visual- 
ized by silver staining. The molecular standards of the markers (kDa; 
prestained SDS-PAGE standards, BIO-RAD) are indicated to the left. 
crude extracts. The specificity of the gel shift complexes is also 
demonstrated by competition with specific but not with non- 
specific competitors (Fig. 3A). These purified fractions were 
SDS-polyacrylamide gel electrophoresed and visualized by sil- 
ver staining (Fig. 4). The molecules of about 70, 80, and 110 
kDA were apparently enriched after the stepwise column puri- 
fication, indicating that the USRE-binding proteins contain at 
least these three proteins, termed ~70, ~80 and ~110, respec- 
tively. 
3.4. ~70 and p80 proteins are human autoantigen Ku-related 
proteins 
We attempted to determine the partial amino-terminal amino 
acid sequence of the three proteins, ~70, ~80, and ~110, as 
described in section 2. Although the N-terminal amino acids of 
p70 and ~110 failed to be determined, probably due to the 
blocking of the N-terminal amino acid, 21 amino acid residues 
at the amino terminus of ~80 were determined: Val-Arg-Ser- 
Gly-Asn-Lys-Ala-Ala-Met-Val-Leu-X-Met-Asp-V~-Gly-Phe- 
X-Met-Ser-Asn (X = not determined). The computer search of 
this amino acid sequence against the Protein Identification Re- 
source sequence bank revealed over 85% homology to the 
amino-terminal sequence of the human autoantigen Ku80 pro- 
tein [33]: Val-Arg-Ser-Gly-Asn-Lys-Ala-Ala-Val-Val-Leu-Cys- 
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Fig. 5. Gel mobility shift assays u ing Jurkat purified nuclear proteins 
(Hep(0.4M) fraction) and “P-labeled USRE oligonucleotide as a probe 
followed by incubation with a control normal human serum (lane 3), 
an anti-Ku@80/p70) serum (lane 2) and saline (lane 1). An arrowhead 
on the right; position of a super shifted complex seen with the anti-Ku 
serum (lane 2). 
Met-Asp-Val-Gly-Phe-Thr-Met-Ser-Asn. As Ku is known to 
be a heterodimer composed of two subunits with molecular 
weights of 70 and 80 kDa, we next examined whether the p70 
and p80 proteins are immunologically Ku-related proteins. The 
result demonstrated that the p70 and p80 proteins were identi- 
fied as the Ku or Ku-related proteins by Western blotting using 
anti-Ku(p801p70) sera from patients with scleroderma- 
polymyositis overlap syndrome (data not shown). Further- 
more, the gel shift induced by the nuclear extract can further 
shift following incubation with an anti_Ku(p80/p70) patient 
serum but not by a control serum (Fig. 5). These data demon- 
strated that the Ku or Ku-related proteins are involved in the 
USRE-binding protein complex, suggesting the possible in- 
volvement of Ku in the US-mediated repression. 
4. Discussion 
Recently, it has been shown that cellular nuclear factors such 
as Ets-1, Ets-2, SPl, TIF-1, Myb and YB-1 are activators of 
HTLV-I LTR-mediated transcription in the absence of tax 
protein [12-l $19,201. Both Myb and Ets proteins are preferen- 
tially expressed at high levels in lymphoid tissues, particularly 
in the CD4’ T cells that are natural targets for HTLV-I infec- 
tion. Small amounts of YB-1 mRNA were also found in the 
lymphoid tissues. Therefore, it is reasonable to believe that 
these nuclear factors may play a crucial role in the expression 
of viral RNA in T cells in vivo. However, several reports have 
shown that the xpression of HTLV-I viral mRNA as a propor- 
tion of total RNA in fresh uncultured peripheral blood 
mononuclear cells (PBMCs) from patients with ATL, TSP/ 
HAM, or asymptomatic HTLV-I carriers is very low, and that 
some viral antigens are expressed only in a small number of 
circulating blood cells in vivo [34-381. This discrepancy predicts 
that the HTLV-I gene expression in PBMCs in vivo is sup- 
pressed. So far, little is known of the suppression mechanisms 
in vivo. Analysis of the repressive lement in the LTR seems 
to provide some important information about the mechanisms. 
Seiki et al. have characterized a &acting repressive lement 
in the LTR U5 segment [17]. When tram-activated with tax 
protein, some constructs of the LTR promoter with the deletion 
mutants within the U5 region showed strong promoter activi- 
ties, while others did not. The differences suggested that the 
negative regulatory element that may function as an RNA 
element is located between +266 and + 347. Moreover, they 
showed that the U5 segment exerts its repressive effect only 
when linked to the R region of the LTR. Recently, Xu et al. 
reported that HTLV-I LTR suppression is associated with cy- 
clic- AMP responsive lement binding protein (CREB) binding 
in the R region (+205 to +227) [21]. 
In this study, our fmdings that the sequences in the U5 region 
exert a repressive ffect on the HTLV-I LTR-directed expres- 
sion in the absence of tax-protein suggested the possibility that 
the U5 region controls basal HTLV-I transcription in initiation 
of viral gene expression. We showed that nuclear extracts from 
Jurkat T cells contain factors that bind to the U5 DNA segment 
(+269 to + 295; USRE) of the LTR. In vivo competition exper- 
iments showed that USRE contains a functional repressive le- 
ment. The binding of the nuclear factors to USRE is specific 
in that they do not form shift bands with non-specific DNA. 
To examine distribution of the USRE-binding proteins in 
various kinds of cells, crude nuclear extracts were prepared 
from 15 human cell lines (Jurkat, Molt-4, CEM, MT-2, MT-4, 
TL-Oml, TL-SU, H582, TOM-l, Daudi, K562, U937, HeLa, 
U251 and NB9) and were analyzed USRE-binding activities by 
the gel mobility shift assay (data not shown). The binding 
activities were detectable in all of the human cell lines exam- 
ined, which include HTLV-I-infected and -uninfected T-cell 
lines and non-T-cell lines. Nuclear extracts from fresh prepara- 
tions of human PBMCs also contained such binding activities. 
These findings indicate that the USRE-binding proteins are 
ubiquitous proteins. 
Our demonstration that the Ku or Ku-related proteins are 
involved in USRE-binding will aid in examining the mechanism 
of the LTR US-mediated repression. Ku, originally identified 
as an antigen recognized by sera from various autoimmune 
patients, is an abundant nuclear protein, and is a heterodimeric 
protein complex present in various mammalian systems [24,25]. 
Although the precise function of the Ku is still unclear, a role 
in transcriptional regulation has been proposed. Ku co-purities 
with DNA-dependent protein kinase that phosphorylates RNA 
polymerase II and many transcriptional factors [39,40]. Ku also 
binds a critical motif in the T-cell receptor j? enhancer [26] and 
the transcriptional control element of the human transferrin 
receptor gene [27]. Moreover, Ku was suggested to be involved 
in repression-mediated own regulation of mouse ribosomal 
gene transcription [41]. Thus, these results may suggest the 
possible involvement of Ku in the US-mediated repression. On 
the other hand, Shindler et al. have reported that Ku also 
co-purifies as contaminants by binding to the termini of DNA 
fragments [42]. In our case, however, it seems unlikely that Ku 
100 K Okwnura et al. IFEBS Letters 356 (1994) 94-100 
binds just DNA termini of the USRE fragment, because the 
non-specific DNA competitor did not inhibit the shift band 
formation in gel mobility shift assays with the “P-labeled 
USRE DNA probe (Fig. 3A). 
We have not yet been successful in sequencing of another 
USRE-binding protein ~110, probably due to the blocking of 
the N-terminal ammo acid. Alternatively, we have tried to iso- 
late cDNA clones encoding ~110 by using a South-Western 
screening method with the 32P-labeled USRE DNA probe. To 
date, we have isolated a clone encoding a novel protein that has 
an ability to bind the USRE segment. We are now examining 
whether this cDNA-encoding protein corresponds to the PllO 
protein (will be published elsewhere). 
Although the biological significances of these Ku-related 
proteins and the ~110 protein remain to be determined, this 
study indicates the possibility that the USRE-binding proteins 
play a role in the USRE-mediated repression primarily at the 
transcriptional level. 
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